Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
Kim IH, Lee IH, Lee JE, Hong SH, Kim TJ, Lee KY, Kim YK, Kim SJ, Sung SW, Park JK, Yoo IR, Kim YS, Kim JO, Kang JH.
Kim IH, et al. Among authors: kim yk, kim jo, kim tj, kim sj, kim ys.
Clin Lung Cancer. 2016 Sep;17(5):e31-e43. doi: 10.1016/j.cllc.2016.01.005. Epub 2016 Feb 2.
Clin Lung Cancer. 2016.
PMID: 26992846